Lupin ( Lupin)

Primary tabs

Lupin's picture

Management

Contact Address

About Lupin

The company was named after the Lupin flower because of the inherent qualities of the flower and what it personifies and stands for. The Lupin flower is known to nourish the land, the very soil it grows in. The Lupin flower is also known to be tolerant of infertile soils and capable of pioneering change in barren and poor climes. The Lupin flower and bean pods have also long been used as food and sources of nourishment, thus protecting and nurturing life.

Lupin press release, blog etc

Tue, 12/30/2025 - 23:03 Mumbai, December 29, 2025: Global pharma major Lupin Limited (Lupin) today announced that it has entered into an exclusive License, Supply and Distribution agreement with Gan & Lee Pharmaceuticals, headquartered in China, for a novel fortnightly GLP-1 rec
Tue, 12/16/2025 - 09:36 Mumbai, December 16, 2025: Global pharma major Lupin Limited (Lupin) today announced that its greenhouse gas (GHG) emissions reduction targets have been officially validated by the Science Based Targets initiative (SBTi). These validations cover all three
Thu, 12/04/2025 - 20:03 Mumbai, Naples, December 04, 2025: Global pharma major Lupin Limited (Lupin) today announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics (Valorum) , a biosimilar specialist in the U.S., for its biosimilar Armlupeg (peg
Fri, 11/28/2025 - 09:39 We are honored to receive the VO 1A rating from CRISIL, reflecting our commitment to social welfare and sustainable growth, said Tushara Shankar, Head CSR, Lupin. This recognition inspires us to expand our innovative programs that support communities and
Fri, 11/14/2025 - 11:30 Mumbai, November 14, 2025: Global pharma major Lupin Limited (Lupin) today announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, Single-Dose Vials, with 180-day CGT exclusivit
Tue, 10/28/2025 - 07:09 It was an honor to attend the ribbon cutting for Lupins new office space, said New Jersey Governor Phil Murphy . Lupins continued investments in New Jersey, evidenced by this expansion in Bridgewater, are fully aligned with my administrations priorities:
Thu, 10/09/2025 - 06:35 Mumbai, Naples, October 09, 2025 : Global pharma major Lupin Limited (Lupin) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere the long-acting injectable (LAI) platform developed by its subsidia
Wed, 10/08/2025 - 18:27 FurtheringU.S.-basedpharmaceuticalcapacityin Coral Springs,Floridatoproducecritical respiratory medicinesandtostrengthen the companys position as a globalrespiratory leader.
Mon, 10/06/2025 - 01:09 Mumbai, Naples, October 3, 2025 : Global pharma major Lupin Limited (Lupin) today announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen, in the United States.
Tue, 08/12/2025 - 06:33 Mumbai, August 12, 2025: Global Pharma major Lupin Limited (Lupin) today announced that it has partnered with Sandoz Group AG (Sandoz), Switzerland, to market and commercialize Lupins biosimilar ranibizumab across multiple regions.
Thu, 07/17/2025 - 19:53 Mumbai, Melbourne, July 17, 2025:: Global pharma major Lupin Limited (Lupin) today announced that the API manufacturing facility of its wholly owned subsidiary, Lupin Manufacturing Solutions (LMS), in Dabhasa, Gujarat, has received the Good Manufacturing
Wed, 07/09/2025 - 16:05 , have entered into a license and supply agreement for commercialization of Lupins biosimilar Certolizumab Pegol, across multiple markets globally.
Mon, 06/16/2025 - 09:49 Mumbai, Naples, Fuzhou, China, June 16, 2025 : Global pharma major Lupin Limited (Lupin) today announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of Tiotropium Dry Powder Inhale
Tue, 06/10/2025 - 03:27 Palghar, Maharashtra, June 09, 2025 Lupin Human Welfare & Research Foundation (Lupin Foundation), the CSR arm of global pharmaceutical leader Lupin Limited (Lupin), in collaboration with the Public Health Department, Government of Maharashtra, flagged of
Mon, 05/26/2025 - 18:45 Global pharma major Lupin Limited (Lupin) will present data from its Phase 1a clinical trial evaluating LNP7457, a PRMT5 inhibitor, at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, from May 30 to June 3, 2025. The p
Mon, 05/26/2025 - 08:33 : Global Pharma major Lupin Limited (Lupin) today announced that it has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupins biosimilar ranibizumab across Lat
Tue, 05/20/2025 - 20:09 Mumbai, Delhi, May 20, 2025 : Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywells Solstice Air (HFO-1234ze cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for pa
Fri, 05/16/2025 - 09:40 Mumbai, Naples, May 15, 2025: Global pharma major Lupin Limited (Lupin) announced the appointment of Punita Lal as an Additional Director (Non-Executive, Independent) to its Board of Directors.